12-year-old Gaza refugee brought to Atlanta as apart of massive medical evacuation
Yassin Alghalban, 12, is among the latest group to escape the conflict, arriving in Atlanta Sunday afternoon.
While searching for his toys in the rubble of their destroyed home on April 12, 2024, the 12-year-old lost both of his legs when an airstrike hit.
Yassin's mother, Fadwa Almasry, said they've been trying to get medical care since then, but have faced several challenges in their attempts to evacuate, including the closure of the Rafah crossing and random security blocks.
Steve Sosebee, co-founder of Heal Palestine, says they have been able to bring dozens of children over to the U.S. over the last year and a half.
[DOWNLOAD: Free WSB-TV News app for alerts as news breaks]
'We actually have the largest single evacuation of injured kids coming to the United States today,' Sosebee told Channel 2's Brittany Kleinpeter.
Sosebee welcomed Yassin and his family on Sunday afternoon, joined by a crowd of metro Atlanta supporters.
'The health sector in Gaza has been destroyed the so the treatment he should be getting in his land among his family and his people is not available to him,' said Sosebee.
Yassin not only lost his legs but also lost his father in a bombing. The 12-year-old and his siblings have been living on one or no meals each day.
'They're all suffering from different levels of malnutrition,' added Sosebee.
Yassin's doctor, who didn't want to be identified for safety and security reasons, shared that the 12-year-old will begin treatment this week, and they are looking at getting him prosthetics.
Through a translator, Yassin's mother shared this sentiment about her son's care.
'I'm very happy as a mom to be able to have this opportunity for him to be treated, and what I want to see is Yassin to walk again. And I want him to get back to normal life, where he's earning an education. I want him to be a teacher or a doctor,' said Almasry.
TRENDING STORIES:
Deputies search Georgia home for wanted woman. They found more than clothes hidden in a dresser
Teen girl, unborn child dies in middle Georgia shooting
VIDEO: Rare congregation of over 300 alligators spotted in southeast Georgia lake
[SIGN UP: WSB-TV Daily Headlines Newsletter]
Solve the daily Crossword
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
10 minutes ago
- Yahoo
Dr. Javad Sajan Does First Facial-Feminization with Simultaneous Hair Transplant Procedure
Seattle Plastic Surgeon Performs Nation's First Combined Facial Feminization & Hair Transplant Surgery SEATTLE, WA / / August 5, 2025 / Dr. Javad Sajan, a top Seattle plastic surgeon and founder of Allure Esthetic Plastic Surgery, has made medical history in the U.S. by performing the nation's first facial feminization surgery (FFS) combined with hair transplant in a single operative session. The milestone procedure was performed on Ember Norman and is featured on offering a detailed look at the surgical planning, technique, and outcomes. The entire surgery, including the hair transplant, qualified for coverage under Norman's gender‑affirming insurance plan. As part of a full facial feminization surgery, Dr. Javad Sajan performed a carefully planned combination of skeletal and soft tissue procedures to transform the patient's facial structure and features. The surgery began with upper facial bone contouring, including frontal bone and orbital bone reduction, and a frontal sinus setback to soften and feminize the upper third of the face. A follicular unit transplant of 1,000 grafts was performed to feminize the hairline. To further feminize the upper face, Dr. Sajan performed a brow lift, elevating the brow position for a more open and feminine expression. In the midface, a mid-facelift and rhinoplasty were performed to enhance facial harmony and refine nasal shape and projection. For the lower face, Dr. Sajan completed a lip lift to shorten the philtrum and improve lip aesthetics. This was followed by chin bone reduction and jaw bone reduction to narrow and sculpt the lower facial contour. This comprehensive transformation reflects the precision and artistry involved in advanced facial feminization surgery. The full surgical journey and before-and-after results can be viewed here. These combined procedures eliminate the need for a second surgery, making the healing process easier and more efficient. Key benefits of this approach include: Single anesthesia event and one recovery timeline A lower and more feminine hairline Minimal scarring Who is an ideal candidate for a same-day FFS+ hair transplant? Ideal candidates for simultaneous FFS and hair transplant surgery include healthy transgender or non-binary patients who are medically cleared for general anesthesia, have realistic expectations, and maintain stable hormone levels for at least six months. Is combining the procedures safe? Combining both procedures in a single session is generally safe; however, all surgery and anesthesia have risks. It eliminates the need for a second anesthesia event, minimizes cumulative swelling, and avoids re-entering previously operated areas, such as a freshly feminized forehead, during a later surgery. How long does the surgery take? The combined procedure typically takes 6 to 12 hours, depending on the extent of facial bone reshaping and the number of hair grafts required. About Dr. Javad Sajan and Allure Esthetic Plastic Surgery: Dr. Javad Sajan is a renowned Seattle-based plastic surgeon, known for his leadership in gender-affirming and facial cosmetic surgery. At Allure Esthetic, Dr. Sajan and his team blend advanced techniques with personalized care to deliver exceptional results. Media Contact:Allure Esthetic Plastic SurgeryPhone: 206-209-0988Website: info@ SOURCE: RealDrSeattle View the original press release on ACCESS Newswire Sign in to access your portfolio
Yahoo
10 minutes ago
- Yahoo
Why Hims & Hers Health Stock Just Dropped
Key Points Hims & Hers Health stock missed on earnings last night. The company grew sales 73% and profits tripled, but Wall Street wanted more. Hims & Hers also reported negative free cash flow for the first half of the year. 10 stocks we like better than Hims & Hers Health › Hims & Hers Health (NYSE: HIMS), the telehealth company famous for selling Ozempic lookalikes over the internet, is tumbling today, down 6.7% through 10:55 a.m. ET after missing in its second-quarter earnings report last night, on both the top and bottom lines. Heading into the report, analysts forecast Hims & Hers would earn $0.23 per share on $552 million in sales -- but Hims & Hers earned only $0.17 per share, and sales were less than $545 million. Hims & Hers' Q2 earnings But was the news really as bad as it seems? After all, while Hims & Hers "missed" on sales, it did still grow sales 73% year over year. That was twice as fast as it grew subscribers, too (31%), indicating that not only are more customers signing up for the company's services, but they're buying more, too. And while Hims & Hers missed on earnings, too, those earnings per share nearly tripled year over year. Really, the only "bad" number I see in the report concerns free cash flow (FCF). Through the first half of this year, Hims & Hers grew its operating cash flow only 13%, to $90 million (within a couple of percentage points of reported net income). However, the company spent massively on capital expenditures -- more than $100 million -- resulting in negative FCF for the first half of 2025. Investors seem unsure what to make of the news. At one point this morning, the stock had recovered all its losses, and even turned green, before falling back into the red. Is Hims & Hers stock a sell? So how should investors react to this conflicting news? At $13.6 billion in market capitalization, Hims & Hers stock costs a pricey 70 times trailing earnings. It's even more expensive when valued on FCF -- about 103 times. These might be acceptable valuations if earnings were to continue tripling year after year. In fact, though, analysts see profits growing only 13% this year, and perhaps 57% next. For the time being, Hims & Hers stock remains too expensive to buy. Should you buy stock in Hims & Hers Health right now? Before you buy stock in Hims & Hers Health, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Hims & Hers Health wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $631,505!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,103,313!* Now, it's worth noting Stock Advisor's total average return is 1,039% — a market-crushing outperformance compared to 181% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of August 4, 2025 Rich Smith has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Hims & Hers Health. The Motley Fool has a disclosure policy. Why Hims & Hers Health Stock Just Dropped was originally published by The Motley Fool
Yahoo
10 minutes ago
- Yahoo
Multiple infections linked to raw milk consumption in Florida, health officials say
The Florida Department of Health is investigating an outbreak of infections linked to drinking unpasteurized milk, officials said this week. The health department issued a bulletin Monday, reporting that 21 people who consumed raw milk from the same farm had been infected with campylobacter and E. coli, with seven of those patients requiring hospitalization. Of the 21 cases, six were children under the age of 10. "Severe complications have been reported for at least two cases," officials said. The health department did not name the farm that produced the raw milk but confirmed the ingredient was linked to the cases. It is illegal to sell raw milk for human consumption in Florida. Raw milk can legally be sold for non-human consumption "as pet or animal food," the health department stated, because it doesn't undergo the same sanitary regulations and can be a source of foodborne illness. "Due to continued recent cases of Campylobacter and Shiga toxin-producing E. coli (STEC) infections linked to a particular farm, the Florida Department of Health is providing information to assist Floridians in making informed decisions about their health," Monday's health alert stated. "Sanitation practices in this farm are of particular concern due to the number of cases." This is a developing story. Please check back for more details. Solve the daily Crossword
